Glenmede Investment Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-947
Closed -$66K 1417
2025
Q2
$66K Buy
+947
New +$54K ﹤0.01% 1347

Other funds holding ACLS

Glenmede Investment Management's ACLS Position: Q3 2025 in Review

Glenmede Investment Management sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 947 shares — an estimated $66K sold.

Glenmede Investment Management first reported a position in ACLS in Q2 2025 and held it in 1 quarter. The position peaked at $66K in Q2 2025. 360 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.

  • Glenmede Investment Management reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
  • Glenmede Investment Management sold 947 Axcelis shares in Q3 2025, an estimated $66K.
  • Glenmede Investment Management first reported a position in Axcelis in Q2 2025 and held it in 1 quarter.
  • Glenmede Investment Management's Axcelis position peaked at $66K in Q2 2025.
  • 360 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.